ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| C Cardiovascular system |
|---|
| C01 Cardiac therapy |
| C02 Antihypertensives |
| C03 Diuretics |
| C04 Peripheral vasodilators |
| C05 Vasoprotectives |
| C07 Beta blocking agents |
| C08 Calcium channel blockers |
| C09 Agents acting on the renin–angiotensin system |
| C10 Lipid modifying agents |
| |
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- ^ "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- ^ "ATC/DDD Index 2021: code C". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2021: code QC". WHO Collaborating Centre for Drug Statistics Methodology.